CompaniesByCap
RIGL
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ · Healthcare

Rigel Pharmaceuticals, Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue294.3M179.3M116.9M120.2M149.2M108.6M59.3M44.5M4.5M20.4M
Gross Profit
Profitability
Operating Income125.5M24.2M-20.5M-55.5M-12.5M-29.0M-69.1M-72.7M-79.6M-69.7M
EBITDA
Net Income367.0M17.5M-25.1M-58.6M-17.9M-29.7M-66.9M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)19M18M17M17M170M169M167M167M147M99M

Rigel Pharmaceuticals, Inc. Income Statement — FAQ

Rigel Pharmaceuticals, Inc. (RIGL) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RIGL's income statement history?

The chart and table above show Rigel Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.